Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 1,799,519 |
|
|||||
| News | - | ||||||
| Day High | 1.57 | Low High |
|||||
| Day Low | 1.47 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| SELLAS Life Sciences Group Inc | SLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.52 | 16:34:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.54 | 1.47 | 1.57 | 1.54 | 1.52 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,089 | 1,799,519 | $ 1.53 | $ 2,747,790 | - | 0.4986 - 1.914 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:34:07 | formt | 390 | $ 1.52 | USD |
SELLAS Life Sciences Group Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 49.06M | 32.06M | - | 0 | -37.34M | -1.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
SELLAS Life Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.42 | 1.57 | 1.27 | 1.40 | 1,054,212 | 0.10 | 7.04% |
| 1 Month | 1.05 | 1.57 | 0.96 | 1.23 | 1,689,311 | 0.47 | 44.76% |
| 3 Months | 0.52 | 1.72 | 0.4986 | 1.06 | 1,454,132 | 1.00 | 192.31% |
| 6 Months | 1.07 | 1.72 | 0.4986 | 0.9737872 | 1,149,902 | 0.45 | 42.06% |
| 1 Year | 1.60 | 1.914 | 0.4986 | 1.05 | 686,617 | -0.08 | -5.00% |
| 3 Years | 7.37 | 15.0789 | 0.4986 | 3.23 | 424,180 | -5.85 | -79.38% |
| 5 Years | 0.957 | 19.38 | 0.1021 | 1.95 | 2,390,867 | 0.563 | 58.83% |
SELLAS Life Sciences Description
| SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. |
